Investment & Financing

FUTURE MINERALS FORUM PARTNERS WITH MCKINSEY FOR GLOBAL THOUGHT LEADERSHIP ON MINERALS

2023-02-14 21:12 3224

RIYADH, Saudi Arabia, Feb. 14, 2023 /PRNewswire/ -- The Future Minerals Forum (FMF), the international conference convened bySaudi Arabia to shape the future of minerals, announced that it has mutually agreed with the international consultancy McKinsey and Co. to be the FMF Knowledge Partners.  ...

Mars Acquisition Corp. Announces Pricing of $60 Million Initial Public Offering

2023-02-14 10:00 2770

NEW YORK, Feb. 13, 2023 /PRNewswire/ -- Mars Acquisition Corp. (the "Company"), a newly incorporated blank check company incorporated as aCayman Islands exempted company formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization or similar busi...

KPS CAPITAL PARTNERS TO ACQUIRE CONTROLLING OWNERSHIP OF PRINCESS YACHTS

2023-02-14 08:20 4312

Investment will Accelerate Company's Growth and Innovation NEW YORK, Feb. 14, 2023 /PRNewswire/ -- KPS Capital Partners, LP ("KPS") announced today that it has entered into a definitive agreement to acquire a controlling equity interest in Princess Yachts (Holdings) Limited, ("Princess Yachts" o...

Via closes financing round at $3.5B valuation, raising $110M to expand TransitTech portfolio

2023-02-13 23:30 4165

Strong demand for Via's software drives rapid growth NEW YORK, Feb. 13, 2023 /PRNewswire/ --  Via, the global leader in TransitTech, today announces it has closed a financing round led by 83North, with participation from new and existing investors including Exor N.V., Pitango, Janus Henderson, CF...

AnPac Bio-Medical Science Enters into Definitive Agreement to Make Another Acquisition to Significantly Expand Scope of Business in the U.S.

2023-02-13 21:00 4658

NEW YORK, Feb. 13, 2023 /PRNewswire/ -- AnPac Bio-Medical Science Co., Ltd. (the "Company") (NASDAQ: ANPC), a company with operations inthe United States andChina announced that on February 12, 2023, the Company, through its subsidiary Foodbase Group Inc., entered into a definitive equity purchas...

Qiming Venture Partners' portfolio company LanzaTech Lists on Nasdaq

2023-02-11 13:47 6578

SHANGHAI, Feb. 11, 2023 /PRNewswire/ -- LanzaTech NZ, Inc. ("LanzaTech"), an innovative leader in carbon capture and transformation and a Qiming Venture Partners portfolio company, listed on Nasdaq onFeb 10 Beijing time, following the completion of its business combination with AMCI Acquisition C...

ASIG Announces Appointment of Co-founder and President Ouyang Yun as CEO

2023-02-10 20:24 5640

Company mourns passing of Andy Tian, reconfirms commitment to business combination with Magnum Opus Acquisition Limited SINGAPORE, Feb. 10, 2023 /PRNewswire/ -- Asia Innovations Group Limited ("ASIG" or "the Company") announced today the appointment of Mr.Ouyang Yun, Co-founder and President of ...

HanAll Biopharma Invests in Interon to Seek Collaboration Opportunities

2023-02-10 20:00 3998

* HanAll will invest in Interon Laboratories, a preclinical-stage biotechnology company focused on treating complex neurological disorders * Interon is developing a new category of immunotherapy for people with neurological and immune disorders starting with autism spectrum disorder SEOUL, So...

Elliott Statement on Dai Nippon Printing

2023-02-10 08:30 2291

LONDON, Feb. 10, 2023 /PRNewswire/ -- Elliott Advisors (UK) Limited ("Elliott"), which advises funds that together hold a significant investment in Dai Nippon Printing ("DNP" or "the Company"), notes yesterday's announcement regarding the Company's new Medium-term Management Plan. Elliott Senior...

AcuraBio expands cGMP plasmid DNA CDMO services with Cytiva's latest single-use purification technology to alleviate supply constraints for mRNA and cell & gene therapies

2023-02-10 04:34 4004

* AcuraBio selects Cytiva's latest two-step purification protocol to offer a productive plasmid DNA service to its customers globally to alleviate supply constraints for mRNA and cell & gene therapies * The latest purification technology will offer efficient processing time for plasmid DNA pr...

Syntach AB announces partnership with Meditrial CRO to drive clinical development of groundbreaking Cardiac Support System

2023-02-10 03:00 4303

LUND, Sweden, Feb. 10, 2023 /PRNewswire/ - Syntach AB ("Syntach") is pleased to announce that it has entered into a partnership agreement with Meditrial Europe Ltd ("Meditrial") to support the clinical and regulatory strategies of Syntach's innovative minimally invasive cardiac support system.  ...

Qiming Venture Partners Celebrates Hesai Technology's IPO on Nasdaq

2023-02-10 00:59 6658

SHANGHAI, Feb. 10, 2023 /PRNewswire/ -- On Feb 9 Beijing time, Hesai Technology ("Hesai"), a global leader in LiDAR technology and Qiming Venture Partners' portfolio company, began trading on Nasdaq. Hesai Technology (NASDAQ: HSAI) offered at$19/ADS and opened at $23.75/ADS, up by 25%, representi...

AnPac Bio-Medical Science Enters into Definitive Agreement to Acquire Fresh2 Ecommerce Inc, a B2B Asian Food E-commerce Platform

2023-02-09 21:00 4051

Transaction expected to fuel the Company's growth in the U.S. food market NEW YORK, Feb. 9, 2023 /PRNewswire/ -- AnPac Bio-Medical Science Co., Ltd. (the "Company") (NASDAQ: ANPC), a company with operations inthe United States andChina focused on early cancer screening and detection and plans to ...

HR Path continues to expand with the merger of US-based company Terra Information Group

2023-02-09 21:00 4175

PARIS, Feb. 9, 2023 /PRNewswire/ -- HR Path welcomes Unites States-based company Terra Information Groupinto the HR Path Group as they further establish their North American expertise and presence.HR Path is a global HR leader for more than 22 years, that supports companies as they undergo digital...

DNA Data Company, Asa Ren, Raised An Oversubscribed US$8.15M To Build An Indonesia Population DNA Database

2023-02-09 18:27 5131

JAKARTA, Indonesia, Feb. 9, 2023 /PRNewswire/ -- Asa Ren, a leading DNA data company based inIndonesia, today announced the closing of a new early stage round of fundings ofUS$ 8.15 Million. This oversubscribed round was co-led by Top Harvest Capital (Silicon ValleyUSA), Kejora Capital (Kejora...

Singapore-based fintech Tazapay raises US$16.9 million in Series A fundraising round, led by Sequoia Capital Southeast Asia

2023-02-09 14:00 3619

SINGAPORE, Feb. 9, 2023 /PRNewswire/ -- Tazapay, a leading fintech company specialising in cross-border payments, announced today that it has raisedUSD 16.9 million in its Series A funding round. Sequoia Capital Southeast Asia led the round, with EscapeVelocity (escp.vc), PayPal Alumni Fund as we...

Humanforce to acquire Wagestream Australia, empowering deskless workers to manage their work, earnings and financial wellbeing in a single workforce management solution

2023-02-09 12:01 3550

SYDNEY, Feb. 9, 2023 /PRNewswire/ -- Humanforce , a Sydney-based global provider of workforce management and payroll solutions, today announced its acquisition of the Australian operations of Wagestream (formerly Earnd),Australia's largest provider of on-demand pay (also ...

Kigen and Skylo work together to bring eSIM and satellite connectivity to expand the potential of 5G IoT

2023-02-08 22:00 5465

LONDON, Feb. 8, 2023 /PRNewswire/ -- Kigen , a global security leader in IoT enablement with its SIM, eSIM, and iSIM technology solutions, andSkylo , a Satellite Network or Non-Terrestrial Network (NTN) operator focused on connecting anything, anywher...

SUMMIT HEALTHCARE ACQUISITION CORP. AND YS BIOPHARMA ANNOUNCE EFFECTIVENESS OF REGISTRATION STATEMENT AND EXTRAORDINARY GENERAL MEETING DATE FOR PROPOSED BUSINESS COMBINATION

2023-02-08 21:30 3904

* Extraordinary general meeting of Summit Healthcare Acquisition Corp.'s shareholders to be held onMarch 1, 2023 at 9:00 a.m. Eastern Time * YS Biopharma is a global biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing new generations of vaccines a...

SUMMIT HEALTHCARE ACQUISITION CORP. AND YS BIOPHARMA ANNOUNCE EFFECTIVENESS OF REGISTRATION STATEMENT AND EXTRAORDINARY GENERAL MEETING DATE FOR PROPOSED BUSINESS COMBINATION

2023-02-08 21:30 3961

* Extraordinary general meeting of Summit Healthcare Acquisition Corp.'s shareholders to be held onMarch 1, 2023 at 9:00 a.m. Eastern Time * YS Biopharma is a global biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing new generations of vaccines a...

1 ... 200201202203204205206 ... 734